undamentalytics Newsletter
Sign in

Omnicell, Inc. cash flow statement

In fiscal 2025, Omnicell, Inc.'s operations generated $127m of cash; it spent $40.4m on capital projects, leaving free cash flow of $86.9m. It returned $77.6m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations46213139556538502510414518623278181188127181
Depreciation and amortisation998131820265852515461738787827977
Stock-based pay109991113152022293445536855394545
Capital spending47915121281315241623294841364039
Free cash flow43142324435331369801291632033014015187143
Free cash flow after stock pay335131532401617−125195118150−38841124298
Share buybacks—013122124500000530520078—
Shares issued——————0014403800—————

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: OMCL vs WAYOMCL vs TEMGDRX vs OMCL

More: Health Care Technology stocks compared, Health Care sector, rankings of US companies

Figures from Omnicell, Inc.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Omnicell, Inc.